packageMidostaurin

midostaurin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Midostaurin is a protein kinase inhibitor used to treat acute myeloid leukemia and, in the European Union, also mastocytosis. It is an approved anticancer medicine authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q6842945 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:midostaurin
ATC codes:L01EX10, L01XE
DrugBank:DB06595
PubChem CID:9829523
ChEBI:63452
Wikidata:Q6842945
formula:C35H30N4O4
molar mass:570.649 g/mol (PubChem CID 9829523)
logP:4.8 (Drugs.Common 25.09, not verified)

Metabolites

CGP52421CGP52421586.648 g/mol (pubchem)
CGP62221CGP62221556.622 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
CGP52421metabolite: CGP52421
CGP62221metabolite: CGP62221